Characterization of HLA Antibodies by C3d Assay and IgG Subclasses in Sensitized Kidney Transplant Patients.

被引：0
|
作者：
Casillas-Abundis, A. [1 ]
Arreola-Guerra, J. M. [1 ]
Albertu, J. [1 ]
Solis-G, M. I. [1 ]
Llorente, L. [1 ]
Granados, J. [1 ]
Vilatoba, M. [1 ]
Cruz-Martinez, R. [1 ]
Morales-Buenrostro, L. [1 ]
Contreras, A. G. [1 ]
机构：
[1] Inst Nacl Ciencias Med & Nutr SZ, Mexico City, DF, Mexico
来源：
AMERICAN JOURNAL OF TRANSPLANTATION | 2019年 / 19卷
关键词：
D O I：
暂无
中图分类号：
R61 [外科手术学];
学科分类号：
摘要：
A155
引用
收藏
页码：651 / 652
页数：2
相关论文
共 50 条
  • [1] EVALUATION OF A C3D SOLID PHASE BEAD ASSAY TO DETECT ANTI- HLA COMPLEMENT FIXING ANTIBODIES IN KIDNEY TRANSPLANTATION
    Ercilla, Guadalupe
    Suarez, Natalia
    Digon, Montserrat
    Oppenheimer, Federico
    Gil-Vernet, S.
    Martorell, Jaume
    TISSUE ANTIGENS, 2014, 84 (01): : 77 - 77
  • [2] The Effect of Tocilizmab Treatment (TCZ-Rx) on IgG Subclasses in HLA-sensitized (HS) Kidney Transplant Patients Treated with TCZ.
    Shin, B. -H.
    Ge, S.
    Choi, J.
    Kahwaji, J.
    Vo, A.
    Petrosyan, A.
    Jordan, S.
    Toyoda, M.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2016, 16 : 604 - 604
  • [3] Clinical Significance of C3d Assay in Kidney Transplant Recipients With Donor-Specific Anti-Human Leukocyte Antigen Antibodies
    Paek, Jin Hyuk
    Kwon, Jungheon
    Lim, Jimin
    Kim, Yaerim
    Park, Woo Yeong
    Jin, Kyubok
    Han, Seungyeup
    TRANSPLANTATION PROCEEDINGS, 2022, 54 (02) : 341 - 345
  • [4] CASE REPORT: THE IMPORTANCE OF C3D ASSAYS IN KIDNEY TRANSPLANT
    Pacquola, E.
    de Franceschi, S.
    Zanotto, D.
    Pol, F.
    Agusson, F.
    del Giudice, L.
    Veronesi, A.
    HLA, 2017, 89 (06) : 396 - 396
  • [5] EVALUATION OF IMMUCOR LIFECODES® C3D DETECTION ASSAY IN PRE-TRANSPLANT PATIENTS
    Daniels, Liesbeth
    Van de Velde, Evelien
    Kerkhofs, Johan
    Emonds, Marie-Paule
    HUMAN IMMUNOLOGY, 2017, 78 : 123 - 123
  • [6] The Effect of Tocilizmab Treatment (TCZ-Rx) on Total IgG and Anti-CMV-IgG Levels in HLA-Sensitized (HS) Kidney Transplant Patients.
    Shin, B. -H.
    Ge, S.
    Choi, J.
    Kahwaji, J.
    Vo, A.
    Petrosyan, A.
    Jordan, S.
    Toyoda, M.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2016, 16 : 707 - 707
  • [7] Presence of C3d Fixing HLA Antibodies Carries Worse Prognosis and Is Associated With Increased Allograft Vasculopathy in Heart Transplant (HT) Patients
    Ducreux, S.
    Dubois, V.
    Boissonnat, P.
    Roussoulieres, A.
    Neidecker, J.
    Obadia, J.
    Dubois, C.
    Sebbag, L.
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2014, 33 (04): : S176 - S177
  • [8] PRESENCE OF C3D FIXING HLA ANTIBODIES CARRY WORSE PROGNOSIS AND IS ASSOCIATED WITH INCREASED ALLOGRAFT VASCULOPATHY IN HEART TRANSPLANT (HT) PATIENTS
    Ducreux, S.
    Dubois, V.
    Boissonnat, P.
    Roussoulieres, A.
    Neidecker, J.
    Obadia, J. F.
    Dubois, C.
    Sebbag, L.
    TRANSPLANT INTERNATIONAL, 2013, 26 : 16 - 16
  • [9] Complement-Fixing Donor-Specific HLA Antibodies Detected By Novel C3d Assay Are Associated With Antibody Mediated Rejection in Heart Transplant Recipients
    Lan, J.
    Hickey, M.
    Cadeiras, M.
    Depasquale, E. C.
    Halnon, N.
    Baas, A.
    Perens, G.
    Nsair, A.
    Kwon, M.
    Khuu, T.
    Ardehali, A.
    Gjertson, D.
    Alejos, J.
    Reardon, L.
    Reed, E. F.
    Deng, M.
    Zhang, Q. F.
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2015, 34 (04): : S130 - S130
  • [10] C3d Assay in Correlation With Single Antigen Bead Assay for Human Leukocyte Antigen Antibodies
    Ko, S. -Y.
    Lee, W.
    Jung, C. W.
    Cho, Y.
    TRANSPLANTATION PROCEEDINGS, 2018, 50 (08) : 2354 - 2358
12345